Armin Reininger
Corporate Officer/Principal presso SWEDISH ORPHAN BIOVITRUM AB
Patrimonio netto: 418 120 $ in data 31/03/2024
Posizioni attive di Armin Reininger
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | 06/01/2017 | - |
| Chief Tech/Sci/R&D Officer | 06/01/2017 | - |
Storia della carriera di Armin Reininger
Precedenti posizioni note di Armin Reininger
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BAXALTA INC | Chief Tech/Sci/R&D Officer | - | - |
| Corporate Officer/Principal | - | - | |
| Ludwig-Maximilians-Universität München | Corporate Officer/Principal | - | - |
Formazione di Armin Reininger
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 2 |
| Germania | 2 |
| Svezia | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Aziende private | 1 |
|---|---|
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
- Borsa valori
- Insiders
- Armin Reininger
- Esperienza
